Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic

Ting Long1, Wei He2, Qi Pan2

  • 1Department of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Abstract

Insights

Microglia P2X4 receptors (P2X4Rs) contribute to chronic migraine (CM) central sensitization by releasing brain-derived neurotrophic factor (BDNF). Blocking this P2X4R-BDNF pathway may prevent migraine chronification.

Area of Science:

  • Neuroscience
  • Molecular Biology

Background:

  • Microglia P2X4 receptors (P2X4Rs) are implicated in chronic migraine (CM) central sensitization.
  • The precise molecular mechanisms linking microglia P2X4Rs and trigeminal nucleus caudalis (TNC) neurons in CM remain unclear.

Purpose of the Study:

  • To elucidate the P2X4R signaling pathway involved in central sensitization in a CM animal model.
  • To investigate the role of microglia P2X4R-BDNF signaling in CM pathogenesis.

Main Methods:

  • Utilized a nitroglycerin (NTG)-induced CM rat model.
  • Assessed mechanical and thermal hypersensitivity.
  • Measured expression of P2X4Rs, BDNF, and p-p38-MAPK in the TNC.
  • Administered P2X4R inhibitor (5-BDBD), agonist (IVM), and TrkB inhibitor (ANA-12).
  • Investigated BDNF release in BV2 microglia cells.

Main Results:

  • NTG administration induced chronic hyperalgesia, upregulating P2X4Rs and BDNF.
  • 5-BDBD and ANA-12 treatment ameliorated NTG-induced hyperalgesia and reduced p-ERK and CGRP release.
  • IVM administration exacerbated hyperalgesia and increased p-ERK and CGRP levels.
  • ATP-induced BDNF release in microglia was dependent on P2X4R activation and p38-MAPK signaling.

Conclusions:

  • Microglia P2X4R activation releases BDNF, promoting TNC neuronal hyper-excitability and contributing to CM central sensitization.
  • Targeting the microglia P2X4R-BDNF axis offers a potential therapeutic strategy for preventing migraine chronification.

Related Concept Videos